Lumen, On a Mission to Hack Your Metabolism, Raises $62M in Funding
The wellness tech company says a recent study shows its hand-held device can help pre-diabetic consumers improve several health indicators
Lumen, a wellness and fitness tech company, has secured $62 million in a Series B funding round.
The Tel Aviv start-up launched by twin sisters with PhDs in physiology promises to hack your metabolism with a simple hold and exhale of a ten-second breath.
The Lumen funding round was led by Pitango Venture Capital, with participation from Hanwha Group, Resolute Ventures, RiverPark Ventures, Unorthodox Ventures, Almeda Capital, and Disruptive VC.
The start-up’s device allows consumers to gain insight into their metabolic health quickly. Previously, measuring metabolism would be conducted in a hospital or clinic with a time-consuming RER test.
“Until now, studying metabolism with the standard equipment was challenging for both researchers and participants. The data collection was minimal and would require participants to come to a clinic for each measurement and a practitioner to analyze the results,” said Merav Mor, chief scientist and co-founder of Lumen. “Now researchers can easily collect multiple data points from participants and build more complex research protocols that unveil new physiological findings.”
The device, $250, uses a sensor to measure CO2 and connects to an app to provide a metabolic health indicator, activity and sleep tracking, workout recommendations, and nutrition coaching. Members can select from three plans ranging in price, one of which offers premium access to Lumen’s team of nutritionists.
Lumen, which recently released results of a clinic study, says it offers pre-diabetic patients the opportunity to improve health indicators, like glucose, HbA1c, and triglycerides with its hand-held metabolism-measuring device.
According to Tomer Cramer, Ph.D., Research Manager at Lumen, the clinical study took place at Tel Aviv Medical Center. The study evaluated Lumen’s ability to improve metabolic parameters in overweight patients with pre-diabetes. Cramer wrote that the $62 million Series B funding round “…is a real testament to the value that metabolic health can add to an individual’s life. Lumens’ core strength lies in its validated scientific foundation.”
The newly acquired funding will be used for business growth, nutrition and lifestyle guidance, and research.
